分類彙整：王長怡博士演講

United BioPharma (UBP), a spinoff company of UBI Asia, was founded by Dr. Chang Yi Wang. Dr. Wang serves as the executive Chairwoman of the Board of Directors and Chief Scientific Officer of UBP. At the invitation of the Taiwanese government in 1998, Dr. Wang set out to establish UBI-Asia, a joint venture between United Biomedical, Inc. (UBI) based in the US and the Taiwan government. She launched a state-of-the-art protein and antibody drug development platform within UBI Asia employing monoclonal antibody B4 as a touch stone and built a competent team with integrated platform technologies to enable development of antibody products from DNA to BLA filings. Other antibody and long acting protein products followed, leading to the spinoff of United Biopharma with a group of rigorously selected antibody products. 繼續閱讀 →

Introduction to Dr. Wang ChangYi 繼續閱讀 →

愛因斯坦曾富哲理地說過：「有時候『重要的』無法計算，能計算的又不重要。」知識，正具有無法量化的重要性。 繼續閱讀 →

Introduction to Dr. Chang Yi Wang – Founder and Chief Scientific Officer of UBI Group of Companies 繼續閱讀 →

【金融家生技領袖高峰論壇】聯合生物製藥 王長怡 董事長 繼續閱讀 →

20170607_元富法說會聯生藥董事長王長怡博士致詞 繼續閱讀 →

歡迎各位、尤其是這兩天從世界各地逺道而來的貴賓、來參加我們聯生藥蛋白質藥廠的落成啟用典禮。這座蛋白質藥廠歷經三年多籌建，它的落成是聯生藥及聯亞集團長期努力、鍥而不捨的心血結晶。 繼續閱讀 →

陳副校長、許副總、各位媒體朋友、以及在座所有貴賓，大家好!
歡迎各位今日到場參加長庚大學與聯亞生技集團的產學合作記者會。 繼續閱讀 →

各位投資及產業先進、各位媒體朋友、以及到場所有貴賓，大家下午好! 歡迎各位今天來參加聯生藥的營運說明會。 繼續閱讀 →

Our honor guests, ladies and gentlemen:
I would like to extend a very warm welcome to our speakers today. We are delighted to have you here to participate and share in our Scientific Symposium: Current Outlook and Future Trend in HIV Treatment 2016. 繼續閱讀 →

從學術界走向產業界，20多個年頭以來，UBI集團創辦人王長怡（圖）除了繼續以獨創的技術平台發展出重要醫療產品，造福全球病患並滿足重要的醫療需求之外。她更強調，要以知識創造經濟！她表示，「通常一個好的產品不但可以帶動一個技術平台、一家公司，亦可逐漸地帶動一個產業，進而串連起台灣整體經濟面」。 繼續閱讀 →

聯合生物製藥(股)公司 (聯生藥，6471) 於今日 (3月12日) 上午九時舉行「聯合生物製藥蛋白質原料廠新建工程」上樑儀式。 繼續閱讀 →

生技中心今天宣布，成功研發的高專一性RAF激(酉每)抑制劑標靶藥物DCBCO0902，將技轉聯亞藥業(6562)，協助聯亞藥進軍癌症標靶治療領域。 繼續閱讀 →